Neutrophil/Lymphocyte Ratio Prognostic in Melanoma

This article originally appeared here.
Share this content:
Neutrophil/Lymphocyte Ratio Prognostic in Melanoma
Neutrophil/Lymphocyte Ratio Prognostic in Melanoma

MONDAY, Sept. 21, 2015 (HealthDay News) -- For patients with metastatic melanoma, neutrophil/lymphocyte ratio (NLR) before initiating ipilimumab treatment is an independent prognostic indicator of poor survival, according to a study published online Sept. 6 in the British Journal of Dermatology.

J. Zaragoza, from the Centre Hospitalier Régional Universitaire de Tours in France, and colleagues examined whether NLR measured before the first infusion correlated with overall survival in a series of 58 patients with metastatic melanoma treated with ipilimumab. The authors examined the influences of NLR and other factors on survival.

The researchers found that in univariate analysis, high NLR (≥4), high absolute neutrophil count, lactate dehydrogenase levels >2, performance status ≥2, symptomatic brain metastases, and corticosteroids before week one correlated with poorer survival. There was a significant association between high NLR and poorer survival in multivariate analysis, which remained significant after adjustment for potential confounders (hazard ratio, 1.21). NLR ≥4 was identified as an independent prognostic factor (hazard ratio, 2.2). Corticosteroid intake before week one was not identified as an independent prognostic factor.

"NLR before initiating ipilimumab treatment in patients with metastatic melanoma is an independent prognostic indicator of poor survival," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC: Too Many Health Care Workers Not Getting Flu Vaccine

CDC: Too Many Health Care Workers Not Getting ...

Vaccination protects both workers and patients

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Patients discharged sooner, become more functional when they leave the hospital

is free, fast, and customized just for you!

Already a member?

Sign In Now »